Infliximab is a medication that falls under the category of biologic drugs, specifically a tumor necrosis factor (TNF) inhibitor. It is commonly used to treat a variety of inflammatory conditions, such as rheumatoid arthritis, Crohn’s disease, ulcerative colitis, psoriasis, and ankylosing spondylitis.

This medication works by targeting and blocking TNF, a protein in the body that plays a key role in the inflammatory response. By inhibiting TNF, Infliximab helps to reduce inflammation and alleviate symptoms associated with these conditions.

It is typically administered through intravenous infusion in a medical setting, with dosing frequency varying depending on the specific condition being treated. Infliximab has been shown to be effective in managing symptoms and improving quality of life for many patients with inflammatory diseases.

As with any medication, there are potential side effects to be aware of when taking Infliximab. These can include increased risk of infections, infusion reactions, liver problems, and potential for development of certain types of cancers. It is important to discuss these risks with your healthcare provider before starting treatment.

Overall, Infliximab can be a valuable treatment option for individuals suffering from inflammatory conditions that have not responded well to other medications. It is important to work closely with your healthcare team to monitor your response to treatment and adjust as needed to ensure the best possible outcomes.